logo
Share SHARE
FONT-SIZE Plus   Neg

Acadia Stock Soars On Positive Results From Antipsychotic Drug Trial - Update

Shares of Acadia Pharmaceuticals Inc. (ACAD: Quote) surged nearly 150 percent in morning trade on Tuesday, after its investigational drug pimavanserin met the primary endpoint in a Phase 3 trial in patients with Parkinson's disease psychosis.

In the pivotal late-stage trial, pimavanserin showed significant antipsychotic efficacy and maintenance of motor control in Parkinson's patients.

Pimavanserin also showed major improvements in nighttime sleep, daytime wakefulness and caregiver burden, and was safe and well tolerated.

The late-stage trial enrolled 199 patients, randomized on a one-to-one basis to receive either 40 mg of pimavanserin or placebo once-daily for six weeks. Patients also received stable doses of their existing therapy throughout. The focus of the trial included concerns such as hallucinations and delusions.

Pimavanserin is Acadia's proprietary small molecule that acts selectively as an antagonist/inverse agonist on serotonin 5-HT2A receptors. Earlier, a late-stage trial of the drug failed to show statistical significance owing to robust improvements among the placebo group.

Parkinson's disease psychosis, or PDP, is a debilitating disorder that develops in up to 60 percent of patients with Parkinson's disease. Currently, there is no FDA-approved therapy to treat PDP in the U.S. PDP, commonly consisting of visual hallucinations and delusions, substantially contributes to the burden of Parkinson's disease. According to the National Parkinson's Foundation, about one million people in the U.S. and from four to six million people worldwide suffer from Parkinson's disease.

Acadia is also evaluating pimavanserin in mid-stage trials for patients with schizophrenia and Alzheimer's disease psychosis.

Acadia stock is trading at $5.56, up $3.38 or 147%, on a volume of about 31 million shares on the Nasdaq.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Online retail giant Amazon.com Inc. (AMZN) is reportedly in talks to buy luxury online fashion retailer Net-a-Porter. The news of acquisition was first reported by Women's Wear Daily, which said the deal would be completed for about 2 billion euros, indicating the biggest acquisition yet by Amazon.... Tim Cook, the CEO of tech giant Apple Inc., in an interview said he intends to give away all his wealth to charity. Cook, in an interview to Fortune, said he plans to donate all his wealth to philanthropic projects after paying for his 10-year old nephew's college education. According to Fortune,... Is it a 'personal life crisis' that led the Germanwings' co-pilot Andreas Lubitz to deliberately lowering the plane carrying 149 people to French Alps mountain? Police is investigating to find evidences to prove this suggestion.
comments powered by Disqus
Follow RTT